KR910002851A - Isooxazolidine derivatives and preparation method thereof - Google Patents

Isooxazolidine derivatives and preparation method thereof Download PDF

Info

Publication number
KR910002851A
KR910002851A KR1019890010565A KR890010565A KR910002851A KR 910002851 A KR910002851 A KR 910002851A KR 1019890010565 A KR1019890010565 A KR 1019890010565A KR 890010565 A KR890010565 A KR 890010565A KR 910002851 A KR910002851 A KR 910002851A
Authority
KR
South Korea
Prior art keywords
derivative
different
same
substituted
alkyl group
Prior art date
Application number
KR1019890010565A
Other languages
Korean (ko)
Other versions
KR920003608B1 (en
Inventor
유성은
이상희
정낙철
김혜령
Original Assignee
채영복
재단법인 한국화학연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 채영복, 재단법인 한국화학연구소 filed Critical 채영복
Priority to KR1019890010565A priority Critical patent/KR920003608B1/en
Publication of KR910002851A publication Critical patent/KR910002851A/en
Application granted granted Critical
Publication of KR920003608B1 publication Critical patent/KR920003608B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음.No content.

Description

이소옥사졸리딘 유도체와 그의 제조방법Isooxazolidine derivatives and preparation method thereof

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (4)

다음의 구조식(Ⅰ)로 표시되는 이소옥사졸리딘 유도체.Isooxazolidine derivatives represented by the following structural formula (I). 여기서, Fn은 그가 결합되어 있는 고리에 n개의 관능기 F가 치환되어 있는 것을 나타내는 바, n은 1,2,3,4, 또는 5이고, F들은 서로 같거나 다를 수 있으며, 각각은 할로겐원자, 니트로기, -R1, -OR1, -SR1또는 -NR1R2로서, 이때 R1및 R2는 서로 같거나 다를 수 있으며, 각각은 수소원자, 탄소수 1내지 6개의 알킬기, 고리알킬기 또는 치환된 폐닐기이고, A와B는 서로 같거나 다를수 있으며, 각각은 탄소원자 또는 질소원자이다.Here, Fn represents that n functional groups F are substituted in the ring to which it is bonded, n is 1,2,3,4, or 5, F may be the same as or different from each other, and each halogen atom, Nitro group, -R 1 , -OR 1 , -SR 1 or -NR 1 R 2 , wherein R 1 and R 2 may be the same or different from each other, and each is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a cyclic alkyl group Or a substituted wasteyl group, A and B may be the same as or different from each other, and each is a carbon atom or a nitrogen atom. (가) 다음 구조식(Ⅱ)의 알데하이드 유도체를 하이드록시아민화합물과 반응시켜서, 다음 구조식(Ⅲ)의 옥심 유도체를 얻고, (나) 상기 옥심 유도체를 할로겐화반응시켜서 다음 구조식(Ⅳ)의 할로겐화옥심 유도체를 얻은 후, 이 할로겐화옥심 유도체를 다음 구조식(Ⅴ)의 스티렌 유도체와 반응시켜서 다음 구조식(Ⅳ)의 화합물을 얻는 다음, (다) 상기 화합물을 아자이드화합물과 반응시켜서 됨을 특징으로 하는 다음의 구조식(Ⅰ)로 표시되는 이소옥사졸리딘유도체의 제조방법.(A) Reacting an aldehyde derivative of the following formula (II) with a hydroxyamine compound to obtain an oxime derivative of the following formula (III), (B) Halogenated oxime derivative to give a halogenated oxime derivative of the following formula (IV) After the reaction, the oxime halide derivative is reacted with a styrene derivative of the following structural formula (V) to obtain a compound of the following structural formula (IV), and then (c) the compound is reacted with an azide compound. The manufacturing method of the iso oxazolidine derivative represented by (I). 여기서, Fn은 그가 결합되어 있는 고리에 n개의 관능기 F가 치환되어 있는 것을 나타내는 바, n은 1,2,3,4, 또는 5이고, F들은 서로 같거나 다을 수 있으며, 각각은 할로겐원자, 니트로기, -R1, -OR1, -SR1또는 -NR1R2로서, 이때 R1및 R2는 서로 같거나 다를 수 있으며, 각각은 수소원자, 탄소수 1내지 6개의 알킬기, 고리알킬기 또는 치환된 폐닐기이고, A와B는 서로 같거나 다를수 있으며, 각각은 탄소원자 또는 질소원자이고, X는 Br, Cl 또는 I 이다.Here, Fn represents that n functional groups F are substituted in the ring to which it is bonded, n is 1,2,3,4, or 5, F may be the same as or different from each other, and each halogen atom, Nitro group, -R 1 , -OR 1 , -SR 1 or -NR 1 R 2 , wherein R 1 and R 2 may be the same or different from each other, and each is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a cyclic alkyl group Or a substituted wasteyl group, A and B may be the same or different from each other, each is a carbon atom or a nitrogen atom, and X is Br, Cl or I. (가) 다음 구조식(Ⅱ)의 말데하이드 유도체를 하이드록시아민화합물과 반응시켜서, 다음 구조식(Ⅲ)의 옥심 유도체를 얻고, (나)는 다음 구조식(Ⅴ)의 스티렌 유도체를 아자이드화합물과 반응시켜서 다음 구조식(Ⅶ)의 테트라졸 유도체를 얻은 다음, (다) 상기 옥심 유도체를 할로겐화반응시켜 다음 구조식(Ⅳ)의 할로겐화옥심 유도체를 얻은 후, 이 할로겐화 옥심 유도체와 상기 테트라졸 유도체를 반응시켜서 됨을 특징으로 하는 다음의 일반식(Ⅰ)로 표시되는 이소옥사졸리딘 유도체의 제조방법.(A) reacting a maldehydride derivative of the following formula (II) with a hydroxyamine compound to obtain an oxime derivative of the following formula (III), and (b) reacting a styrene derivative of the following formula (V) with an azide compound To obtain a tetrazole derivative of the following structural formula (iii), and then (c) halogenate the oxime derivative to obtain a halogenated oxime derivative of the following structural formula (IV), and then react the halogenated oxime derivative with the tetrazole derivative. A method for producing an isooxazolidine derivative represented by the following general formula (I). 여기서, Fn은 그가 결합되어 있는 고리에 n개의 관능기 F가 치환되어 있는 것을 나타내는 바, n은 1,2,3,4, 또는 5이고, F들은 서로 같거나 다를 수 있으며, 각각은 할로겐원자, 니트로기, -R1, -OR1, -SR1또는 -NR1R2로서, 이때 R1및 R2는 서로 같거나 다를 수 있으며, 각각은 수소원자, 탄소수 1내지 6개의 알킬기, 고리알킬기 또는 치환된 폐닐기이고, A와B는 서로 같거나 다를수 있으며, 각각은 탄소원자 또는 질소원자이고, X는 Br, Cl 또는 I 이다.Here, Fn represents that n functional groups F are substituted in the ring to which it is bonded, n is 1,2,3,4, or 5, F may be the same as or different from each other, and each halogen atom, Nitro group, -R 1 , -OR 1 , -SR 1 or -NR 1 R 2 , wherein R 1 and R 2 may be the same or different from each other, and each is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a cyclic alkyl group Or a substituted wasteyl group, A and B may be the same or different from each other, each is a carbon atom or a nitrogen atom, and X is Br, Cl or I. 다음의 구조식(Ⅰ)포 표시되는 이소옥사졸리딘 유도체를 유효성분으로 함유하는 심장순환기계 질환 치료에 조성물A composition for the treatment of cardiac circulatory diseases comprising the isooxazolidine derivative represented by the following structural formula (I) as an active ingredient 여기서, Fn은 그가 결합되어 있는 고리에 n개의 관능기 F가 치환되어 있는 것을 나타내는 바, n은 1,2,3,4, 또는 5이고, F들은 서로 같거나 다를 수 있으며, 각각은 할로겐원자, 니트로기, -R1, -OR1, -SR1또는 -NR1R2로서, 이때 R1및 R2는 서로 같거나 다를 수 있으며, 각각은 수소원자, 탄소수 1내지 6개의 알킬기, 고리알킬기 또는 치환된 폐닐기이고, A와B는 서로 같거나 다를수 있으며, 각각은 탄소원자 또는 질소원자이다.Here, Fn represents that n functional groups F are substituted in the ring to which it is bonded, n is 1,2,3,4, or 5, F may be the same as or different from each other, and each halogen atom, Nitro group, -R 1 , -OR 1 , -SR 1 or -NR 1 R 2 , wherein R 1 and R 2 may be the same or different from each other, and each is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, or a cyclic alkyl group Or a substituted wasteyl group, A and B may be the same as or different from each other, and each is a carbon atom or a nitrogen atom. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019890010565A 1989-07-26 1989-07-26 Isooxazolidine derivatives and its preparation process KR920003608B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890010565A KR920003608B1 (en) 1989-07-26 1989-07-26 Isooxazolidine derivatives and its preparation process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019890010565A KR920003608B1 (en) 1989-07-26 1989-07-26 Isooxazolidine derivatives and its preparation process

Publications (2)

Publication Number Publication Date
KR910002851A true KR910002851A (en) 1991-02-26
KR920003608B1 KR920003608B1 (en) 1992-05-04

Family

ID=19288405

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890010565A KR920003608B1 (en) 1989-07-26 1989-07-26 Isooxazolidine derivatives and its preparation process

Country Status (1)

Country Link
KR (1) KR920003608B1 (en)

Also Published As

Publication number Publication date
KR920003608B1 (en) 1992-05-04

Similar Documents

Publication Publication Date Title
EP0358154A3 (en) Novel cyclobutane derivative and process for producing same
KR880006206A (en) Quinazolinone derivatives and preparation methods thereof
KR910000657A (en) Oxa- or thia-zoline derivatives
KR890006599A (en) Heterocyclic derivatives, their preparation and radiation sensitive and antiviral agents containing them as active ingredients
KR890005141A (en) Process for preparing methylene derivative of androstar-1,4-diene-3,17-dione
KR880001677A (en) β-lactam compounds, methods for their preparation, pharmaceuticals for the treatment of bacterial infectious diseases containing them and intermediates for their synthesis
KR880003626A (en) Usage of 2 ', 3'-didioxycytidine-2'-ene (2', 3'-didioxy-2 ', 3'-didihydrocytidine) in the treatment of patients infected with retrovirus
FR2366285A1 (en) (3-AMINO-5-SUBSTITUE-6-FLUOROPYRAZINOYL OR PYRAZAMIDO) GUANIDINES AND THEIR DERIVATIVES CARRYING SUBSTITUTIONS FOR NITROGEN ATOMS OF THE GUANIDINE CORE, USEFUL AS MEDICINAL PRODUCTS
KR910000647A (en) Naphthylamino- and naphthyloxy-pyridineamine and related compounds, methods for their preparation and their use as dermatitis agents
KR960031442A (en) Use of phenylcyclohexylcarboxamide
KR920012052A (en) Benzoxazinone and Benzothiazinone Derivatives Acting on the Cardiovascular System
KR910002851A (en) Isooxazolidine derivatives and preparation method thereof
FR2400008A1 (en) ANTI-HYPERTENSIF AGENTS
KR850006171A (en) Method for preparing pyrrolidinone derivatives
KR910016691A (en) Novel substituted-amine compounds and preparation methods thereof
KR940005600A (en) Thiosemicarbazone derivatives
FR2366311A1 (en) PROCESS FOR THE PREPARATION OF POLYHALOGENIC STEROIDS USEFUL AS MEDICINAL PRODUCTS
OA04881A (en) Process for the preparation of new amidoxime derivatives.
EP0772630B1 (en) Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same
KR910011839A (en) Imidazolidine Derivatives, Methods for Making the Same, and Insecticides Containing the Same
KR870006040A (en) Substituted 4-fluoro-isoindolin, methods for preparing and using the same, and preparations containing them
KR830006237A (en) Method for preparing carbamoyloxyamino-1,4-benzodiazepine
US3632492A (en) Process for the manufacture of 3-formylrifamycin-sv
KR840002821A (en) Method for preparing N- (2,3-epoxypropylene) -N-aralkylsulfonamide derivative
ATE34740T1 (en) (BIS(HYDROXYMETHYL)METHYL)-ISOCHINOLINE DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020208

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee